T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Marathon Petroleum
MPC
$97.8B
| $37.2M | 0.01% |
953,378
+20,780
| +2% | +$919K |
|
|
AVX
952
DELISTED
AVX Corporation
AVX
| $37.2M | 0.01% |
2,800,402
-6,000
| -0.2% | -$79.6K |
|
|
SASR
953
DELISTED
Sandy Spring Bancorp Inc
SASR
| $37.2M | 0.01% |
1,492,480
+9,100
| +0.6% | +$220K |
|
|
NUAN
954
DELISTED
Nuance Communications, Inc.
NUAN
| $37.1M | 0.01% |
2,285,146
-1,719,983
| -43% | -$24.9M |
|
955
Designer Brands
DBI
$311M
| $36.7M | 0.01% |
1,313,462
-10,733,700
| -89% | -$338M |
|
|
CLC
956
DELISTED
Clarcor
CLC
| $36.4M | 0.01% |
588,420
-34,810
| -6% | -$2.01M |
|
957
Gibraltar Industries
ROCK
$1.46B
| $36.4M | 0.01% |
2,344,105
-530,790
| -18% | -$8.8M |
|
958
Fluor
FLR
$6.96B
| $36.1M | 0.01% |
469,410
-168
| -0% | -$12.8K |
|
959
Universal Logistics Holdings
ULH
$518M
| $36M | 0.01% |
1,420,713
+118,920
| +9% | +$3.01M |
|
|
COL
960
DELISTED
Rockwell Collins
COL
| $36M | 0.01% |
460,911
+250
| +0.1% | +$19.6K |
|
|
TUES
961
DELISTED
Tuesday Morning Corp
TUES
| $36M | 0.01% |
2,018,330
+1,084,740
| +116% | +$16.9M |
|
962
Teekay Tankers
TNK
$2.81B
| $35.8M | 0.01% |
1,043,595
+51,036
| +5% | +$1.5M |
|
|
BEE
963
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
| $35.8M | 0.01% |
3,055,710
+343,200
| +13% | +$3.71M |
|
964
Hershey
HSY
$37B
| $35.4M | 0.01% |
364,021
+17,200
| +5% | +$1.69M |
|
965
Employers Holdings
EIG
$864M
| $35.4M | 0.01% |
1,673,090
+180,311
| +12% | +$3.77M |
|
966
Helix Energy Solutions
HLX
$1.49B
| $35.2M | 0.01% |
1,338,456
+53,919
| +4% | +$1.28M |
|
|
MIG
967
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
| $35.1M | 0.01% |
4,881,103
-500
| -0% | -$3.15K |
|
|
GNMK
968
DELISTED
GenMark Diagnostics, Inc
GNMK
| $34.9M | 0.01% |
2,582,354
-77,546
| -3% | -$809K |
|
|
PRO
969
DELISTED
PROS Holdings
PRO
| $34.9M | 0.01% |
1,318,860
+121,870
| +10% | +$3.17M |
|
970
OGE Energy
OGE
$9.69B
| $34.9M | 0.01% |
892,224
-1,077,199
| -55% | -$39.4M |
|
971
Burlington
BURL
$22.3B
| $34.9M | 0.01% |
1,094,043
+359,123
| +49% | +$10.4M |
|
|
CERN
972
DELISTED
Cerner Corp
CERN
| $34.8M | 0.01% |
674,432
-581,514
| -46% | -$30.6M |
|
973
Steven Madden
SHOO
$3.49B
| $34.5M | 0.01% |
1,507,278
+66,825
| +5% | +$1.5M |
|
|
TESO
974
DELISTED
Tesco Corp
TESO
| $34.5M | 0.01% |
1,614,748
+1,419,548
| +727% | +$29.1M |
|
975
T. Rowe Price
TROW
$23.8B
| $34.4M | 0.01% |
407,394
+25,200
| +7% | +$2.06M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.